Indivior Pharmaceuticals Inc (INDV) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Indivior Pharmaceuticals Inc (INDV) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

INDV

Market Closed

Indivior Pharmaceuticals Inc

NASDAQHealthcare Drug Manufacturers - Specialty & Generic

838 employees

CEO: Joseph J. Ciaffoni

Founded: 2014

$40.53

+$0.00(+NaN%)

Market Cap

5.06B

Beta

1.15

52W Range

N/A

Dividend Yield

1.57%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

80.1%

3.8%

CAGR: 10.6%

Profit after direct costs

Operating Margin

21.4%

728.1%

CAGR: 5.6%

Core business profitability

Net Margin

16.9%

10400.0%

CAGR: 0.6%

Bottom line profitability

Revenue Growth

4.3%

YoY

CAGR: 11.9%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how INDV allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

80.1%

$993.00M

Operating Margin

21.4%

$265.00M

Net Margin

16.9%

$210.00M

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	791.00M	901.00M	1.09B	1.19B	1.24B	4.3%
Cost of Revenue	(127.00M)	(151.00M)	(174.00M)	(231.00M)	(246.00M)	6.5%
Gross Profit	664.00M	750.00M	919.00M	957.00M	993.00M	3.8%
Operating Expenses
Research & Development	(52.00M)	(74.00M)	(116.00M)	(107.00M)	(97.00M)	-9.3%
Selling, General & Administrative	(431.00M)	(469.00M)	(569.00M)	(618.00M)	(634.00M)	2.6%
General & Administrative	(239.00M)	(251.00M)	(333.00M)	(363.00M)	(319.00M)	-12.1%
Selling & Marketing	(192.00M)	(218.00M)	(236.00M)	(255.00M)	(315.00M)	23.5%
Depreciation & Amortization	(22.00M)	(16.00M)	(15.00M)	(29.00M)	(20.00M)	-31.0%
Operating Income (EBIT)	213.00M	-81.00M	-156.00M	32.00M	265.00M	728.1%
Non-Operating Items
Interest Income	4.00M	19.00M	43.00M	23.00M	22.00M	-4.3%
Interest Expense	(26.00M)	(29.00M)	(35.00M)	(41.00M)	(45.00M)	9.8%
Other Income/Expenses (Net)	-23.00M	-8.00M	7.00M	-18.00M	-26.00M	44.4%
Income Before Tax	190.00M	-89.00M	-149.00M	14.00M	239.00M	1607.1%
Income Tax Expense	(15.00M)	(44.00M)	(20.00M)	(11.00M)	(29.00M)	163.6%
Net Income	205.00M	-44.00M	-129.00M	2.00M	210.00M	10400.0%
Per Share Metrics
Earnings Per Share (Basic)	$1	$-0	$0	$0	$2	11025.8%
Weighted Avg Shares Outstanding	145.66M	139.01M	137.31M	132.00M	125.00M	-5.3%
Weighted Avg Shares Outstanding (Diluted)	154.23M	139.01M	141.80M	133.00M	128.00M	-3.8%
EBITDA	238.00M	-46.00M	-99.00M	84.00M	304.00M	261.9%

Explore INDV

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

INDV in the Healthcare

Mid Cap

Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →